Search
for
Sort by
Research 601–630 of 1000+
- Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
- Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden Noac Registry (NCT01588119)
- Trichologist, Dermatotrichologist, or Trichiatrist? A Global Perspective on a Strictly Medical Discipline
- Oral Lichen Planus
- Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome
- Urticaria induced by laser epilation: A clinical and histopathological study with extended follow‐up in 36 patients
- Associations among hair loss, oral sulfur-containing gases, and gastrointestinal and metabolic linked diseases in Japanese elderly men: pilot study
- The association of medications and supplements with human male reproductive health: a systematic review
- The Effectiveness of Oral Mini-Pulse Methylprednisolonein - the Treatment of Alopecia Areata in Vietnam
- Bullous Lichen Planus treated with Oral Minipulse Therapy: A Rare Case Report
- PCOS and Obesity: Contraception Challenges
- Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment
- Antiseizure Medication-Induced Alopecia: A Literature Review
- Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data
- Diagnosis and treatments of hirsutism: where are we?
- Emulgel Considered as Anovel Type of Dosage Form for Topical Application
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Telogen effluvium: a review
- Management of Toxicities of Targeted Therapies
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Contraindicated use of 5-alpha-reductase inhibitors in women
- Dermatologic Care of the Transplant Patient
- CONTRACEPTION AND THE SKIN
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Skin
- Patterns of psychotropic medication prescribing and potential drug-hormone interactions among transgender and gender-diverse adults within 2 years of hormone therapy
- Diagnosis and management of hair loss in children
- Hair Disorders